Compare Nippon India Pharma Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.85
2.82
NAV
₹599.20
₹349.81
Fund Started
10 May 2004
01 Aug 2005
Fund Size
₹8365.40 Cr
₹1143.58 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 30 days.
1 Year
4.96%
9.98%
3 Year
21.76%
25.97%
5 Year
12.63%
13.92%
Equity
98.70%
95.25%
Cash
1.29%
4.74%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.85% |
Lupin Ltd. | 7.95% |
Dr. Reddy's Laboratories Ltd. | 7.04% |
Divi's Laboratories Ltd. | 6.61% |
Cipla Ltd. | 5.47% |
Apollo Hospitals Enterprise Ltd. | 5.01% |
Medplus Health Services Ltd. | 3.78% |
Vijaya Diagnostic Centre Ltd. | 3.36% |
Sai Life Sciences Ltd. | 3.27% |
Ajanta Pharma Ltd. | 3.19% |
Sun Pharmaceutical Industries Ltd. | 9.49% |
Ajanta Pharma Ltd. | 5.84% |
Lupin Ltd. | 4.23% |
Apollo Hospitals Enterprise Ltd. | 3.54% |
Divi's Laboratories Ltd. | 3.45% |
Glenmark Pharmaceuticals Ltd. | 3.35% |
Dr. Reddy's Laboratories Ltd. | 3.35% |
Gland Pharma Ltd. | 3.30% |
Fortis Healthcare Ltd. | 3.23% |
Alkem Laboratories Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
10 May 2004
01 Aug 2005
